Kronox Lab Sciences Ltd. (KRONOX.NS) Stock Overview
Explore Kronox Lab Sciences Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Kronox Lab Sciences Ltd. (KRONOX.NS)
Key Financials
Key Financials
Market Cap
8B
P/E Ratio
27.80
EPS (TTM)
$7.46
ROE
0.28%
KRONOX.NS Stock Analysis & Investment Overview (NSE)
Our AI-powered analysis of Kronox Lab Sciences Ltd. (NSE: KRONOX.NS) gives investors deep insight into how the stock performs on the NSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Kronox Lab Sciences Ltd.'s NSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of KRONOX.NS on the NSE shows an RSI of 77.50, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $148.61 for the NSE listing.
Key metrics behind Kronox Lab Sciences Ltd.'s NSE-traded stock include a P/E ratio of 27.80 and a market capitalization of 8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of KRONOX.NS on the NSE.